Blood cancer
Jump to section: Chronic Lymphocytic Leukemia - Acute Myeloid Leukemia - Other blood cancers
AbbVie is committed to transforming standards of care in the treatment and management of blood cancers with significant unmet needs, enabling patients to live longer without disease progression.
Leading science
All cells, including cancer cells, undergo a natural, controlled
process known as apoptosis or regulated cell death. In some blood
cancers, certain proteins build up and prevent cancer cells from
undergoing apoptosis.
An enzyme called Bruton’s tyrosine kinase, or BTK, is abnormally activated in some blood cancers, causing B cells (white blood cells whose primary role is to produce antibodies) to grow uncontrollably and crowd out normal cells. We are leaders in the research and development of targeted medicines that inhibit the reproduction of cancer cells (B-cell signaling) or enable their death (regulated cell death or apoptosis).